Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

JNJ - Johnson & Johnson

Close
165.86
1.630   0.983%

Share volume: 7,488,754
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) : 0.87%

PREVIOUS CLOSE
CHG
CHG%
$164.23
1.63
0.99%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
71%
Profitability 81%
Dept financing 36%
Liquidity 70%
Performance 70%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.82%
1 Month
3.59%
3 Months
15.03%
6 Months
4.28%
1 Year
4.51%
2 Year
8.37%
Key data
Stock price
$165.86
P/E Ratio 
10.50
DAY RANGE
$163.81 - $165.98
EPS 
$15.42
52 WEEK RANGE
$140.50 - $165.98
52 WEEK CHANGE
$0.07
MARKET CAP 
399.265 B
YIELD 
2.90%
SHARES OUTSTANDING 
2.407 B
DIVIDEND
$1.24
EX-DIVIDEND DATE
08/27/2024
NEXT EARNINGS DATE
10/15/2024
BETA 
0.10
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,493,323
AVERAGE 30 VOLUME 
$6,831,032
Company detail
CEO: Alex Gorsky
Region: US
Website: https://www.jnj.com/
Employees: 152,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.

Recent news